Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 26, 2020
Dec. 28, 2019
Current assets:    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 5,865 $ 4,194
Short-term investments 2,292 1,082
Trading assets 15,738 7,847
Accounts receivable, net of allowance for doubtful accounts 6,782 7,659
Inventories 8,427 8,744
Assets held for sale 5,400 0
Other current assets 2,745 1,713
Total current assets 47,249 31,239
Property, plant and equipment, net 56,584 55,386
Equity investments 5,152 3,967
Other long-term investments 2,192 3,276
Goodwill 26,971 26,276
Identified intangible assets, net 9,026 10,827
Other long-term assets 5,917 5,553
Total assets 153,091 136,524
Current liabilities:    
Short-term debt 2,504 3,693
Accounts payable 5,581 4,128
Accrued compensation and benefits 3,999 3,853
Other accrued liabilities 12,670 10,636
Total current liabilities 24,754 22,310
Debt 33,897 25,308
Contract Liabilities 1,367 1,368
Income taxes payable, non-current 4,578 4,919
Deferred income taxes 3,843 2,044
Other long-term liabilities 3,614 2,916
Commitments and Contingencies (Note 19)
Temporary equity 0 155
Stockholders' equity:    
Preferred stock, $0.001 par value, 50 shares authorized; none issued 0 0
Common stock, $0.001 par value, 10,000 shares authorized; 4,062 shares issued and outstanding (4,290 issued and outstanding in 2019) and capital in excess of par value 25,556 25,261
Accumulated other comprehensive income (loss) (751) (1,280)
Retained earnings 56,233 53,523
Total stockholders' equity 81,038 77,504
Total liabilities, temporary equity, and stockholders' equity $ 153,091 $ 136,524